Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COLDWAR-PLUS
- Development stage
- Unknown
- Lead developer
- Invision Medi Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
COLDWAR-PLUS is a multi-ingredient oral tablet formulation marketed by Invision Medi Sciences, an Indian pharmaceutical company. It is indicated for the treatment of the common cold and upper respiratory symptoms, providing relief from pain, fever, nasal congestion, and allergic symptoms. While the specific composition of the "PLUS" variant is not explicitly detailed in public records, it belongs to a product line where the base formulation (COLDWAR) contains paracetamol (analgesic/antipyretic), phenylephrine (decongestant), chlorpheniramine (antihistamine), and caffeine (stimulant/analgesic adjuvant). As a branded generic product, it is distributed through a pharma franchise (PCD) model in India to provide comprehensive multi-symptom relief for cold, cough, and allergies.
- Brand names
- COLDWAR-PLUSCOLDWAR-PLUS Tablets
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADOR (Adenosine receptors)ADRA1A (α1A)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on COLDWAR-PLUS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COLDWAR-PLUS.